GSA Capital Partners’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-99
Closed -$114K 1871
2018
Q3
$114K Buy
99
+39
+65% +$35.9K 0.01% 1544
2018
Q2
$51K Buy
+60
New +$49.8K ﹤0.01% 1622
2017
Q3
Sell
-51
Closed -$58K 1950
2017
Q2
$58K Buy
+51
New +$62.1K ﹤0.01% 1621

Other funds holding HSTO

GSA Capital Partners's HSTO Position: Q4 2018 in Review

GSA Capital Partners sold out of Histogen Inc. Common Stock (HSTO) in Q4 2018, closing a stake of 99 shares — an estimated $114K sold.

GSA Capital Partners first reported a position in HSTO in Q2 2017 and held it in 3 quarters. The position peaked at $114K in Q3 2018. 52 funds tracked by Wall St. Rank hold HSTO as of Q4 2018.

  • GSA Capital Partners reported no remaining Histogen Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • GSA Capital Partners sold 99 Histogen Inc. Common Stock shares in Q4 2018, an estimated $114K.
  • GSA Capital Partners first reported a position in Histogen Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • GSA Capital Partners's Histogen Inc. Common Stock position peaked at $114K in Q3 2018.
  • 52 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2018.

Based on GSA Capital Partners's 13F filing for Q4 2018, filed 12 Feb 2019.